BRAVA DIAGNOSTICS
Brava Diagnostics develops and commercializes acute care diagnostic products based on the MBio diagnostics rapid testing platform. It is seeking seed financing to fund product development for rapid multiplex point-of-care tests for acute care settings. The core platform uses evanescent planar waveguide technology was developed by MBio. Products have been commercialized for applications outside of human health. Brava's in-vitro diagnostics applications will be for cardiac markers, a $2.3 billion worldwide market. Our first indications will be to assess chest pain and shortness of breath in the emergency department. The next assays will address sepsis, the highest cost disease state in U.S. health systems.
BRAVA DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2018-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.bravadx.com
Total Employee:
1+
Status:
Active
Contact:
(661) 993-4085
Email Addresses:
[email protected]
Total Funding:
4 M USD
Technology used in webpage:
SPF Liquid Web Ninja Forms ParkLogic DNS
Similar Organizations
Cartilix
Cartilix develops and commercializes biomaterials to repair damaged tissues in articular joints and other applications.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Celerus Diagnostics
Celerus Diagnostics develops solutions for anatomic pathology, provides clinicians with diagnostic information, and advances patient care.
Exosome Diagnostics
Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.
Genevolve Vision Diagnostics
Genevolve Vision Diagnostics researches, designs, and commercializes non-invasive molecular diagnostic treatments for clinical apps.
Haystack Dx
Haystack Dx developed a complete solution to address the clinical unmet need to improve the diagnostic procedure for neuromuscular disorder.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Ocutronics
Ocutronics develops technology for retinal imaging or "fundus" cameras used for the diagnosis of diabetic retinopathy.
Oxonica
Oxonica develops and commercializes advanced nanomaterials for UV protection, security, and biodiagnostics applications.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Aspira Women's Health
Aspira Women's Health develops and commercializes diagnostic tests that address unmet needs in gynecologic oncology and women’s health.
Current Employees Featured
Founder
